The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells

Overview of attention for article published in Breast Cancer Research and Treatment, November 2010

Altmetric Badge

Mentioned by

patent: 1 patent

Readers on

mendeley: 38 Mendeley

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

Methods and Models for Determining Likelihood of Cancer Drug Treatment Success Utilizing…

Application US-20150254433-A1

United States of America